Thank you for the question, if blood transfusion is the current mode of treatment, then yes our researach will definitely be of help. In addition, for people requiring regular transfusions, the cells we manufacture would theoretically be better in terms of blood type matching and risk of immune rejected (also known as alloimmunization)